Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Isin Sinem Bagci"'
Autor:
Amy S. Paller, Shireen V. Guide, Diego Ayala, Mercedes E. Gonzalez, Anne W. Lucky, Isin Sinem Bagci, M. Peter Marinkovich
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground/purpose Dystrophic epidermolysis bullosa (DEB), a rare genetic skin disease caused by loss-of-function mutations in COL7A1, the gene encoding type VII collagen (COL7), is characterized by skin blistering, scarring, and extracutaneo
Externí odkaz:
https://doaj.org/article/4d22581de2c841f09a639f4a31802fdc
Autor:
Irina Gurevich, Pooja Agarwal, PeiPei Zhang, John A. Dolorito, Stacie Oliver, Henry Liu, Nicholas Reitze, Nikhil Sarma, Isin Sinem Bagci, Kunju Sridhar, Visesha Kakarla, Vamsi K. Yenamandra, Mark O’Malley, Marco Prisco, Sara F. Tufa, Douglas R. Keene, Andrew P. South, Suma M. Krishnan, M. Peter Marinkovich
Publikováno v:
Nature Medicine. 28:780-788
Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis associated with blistering, wounding, and scarring caused by mutations in COL7A1, the gene encoding the anchoring fibril component, collagen VII (C7). Here, we evaluated b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce9c26f71edbe1ea4feaf5906f51c6c4
https://doi.org/10.1038/s41591-022-01737-y
https://doi.org/10.1038/s41591-022-01737-y
Autor:
Isin Sinem Bagci, Daniela Hartmann
Publikováno v:
Cutaneous Atlas of Ex Vivo Confocal Microscopy ISBN: 9783030893156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b48595eb968df677450955720c63e12
https://doi.org/10.1007/978-3-030-89316-3_15
https://doi.org/10.1007/978-3-030-89316-3_15
Autor:
Isin Sinem Bagci
Publikováno v:
Turk Dermatoloji Dergisi, Vol 10, Iss 3, Pp 126-127 (2016)
Since the beginning of 2016, I have been working as a guest researcher in Ludwig-Maximilian University, Department of Dermatology and Allergology in Munich. In this paper, I aimed to share my ongoing studies, my observations and some necessary inform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::06f098dbaa8a1f95c289a0c769acf910
http://www.turkdermatolojidergisi.com/article_10846/My-Research-Abroad-Experience-First-Six-Months-In-Ludwig-maximilian-University
http://www.turkdermatolojidergisi.com/article_10846/My-Research-Abroad-Experience-First-Six-Months-In-Ludwig-maximilian-University
Autor:
Sebastian Krammer, Christian Krammer, Suzanna Salzer, Işin Sinem Bağci, Lars E. French, Daniela Hartmann
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
For many types of cancer, immune checkpoint inhibitors have proven to be a highly effective treatment. The monoclonal anti-PD-1 antibody nivolumab stimulates the immune system and is one of the newest treatment options for non-small cell lung cancer.
Externí odkaz:
https://doaj.org/article/d1f181430b77412b9623fdd80a434520